Angiodynamics, inc. (ANGO)
Income statement / Yearly
May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10
Net sales

270,634

261,655

269,788

353,890

356,534

354,425

341,916

221,917

215,750

216,035

Cost of sales (exclusive of intangible amortization)

114,634

117,799

125,838

179,574

180,738

174,251

173,402

96,608

90,047

89,066

Gross profit

156,000

143,856

143,950

174,316

175,796

180,174

168,514

125,309

125,703

126,969

Operating expenses:
Research and development

28,258

24,338

24,148

25,053

26,594

28,124

26,319

20,511

21,373

19,275

Sales and marketing

76,829

73,109

74,865

83,743

82,351

85,305

76,121

64,505

58,123

60,923

General and administrative

34,902

30,991

31,133

30,583

30,031

26,902

26,186

19,033

17,828

16,437

Amortization of intangibles

17,100

13,900

14,600

17,964

17,966

16,600

16,617

9,309

9,234

9,463

Change in fair value of contingent consideration

-6,776

250

-15,261

948

-8,096

-1,908

1,583

0

0

-

Acquisition, restructuring and other items, net

15,127

15,432

27,510

12,591

26,257

10,873

13,800

15,859

7,182

-

Medical device excise tax

0

0

-1,837

2,416

4,142

3,829

1,600

0

0

-

Total operating expenses

165,396

158,026

155,125

173,298

179,245

169,687

162,226

129,217

113,740

106,098

Operating loss

-9,396

-14,170

-11,175

1,018

-3,449

10,487

6,288

-3,908

11,963

20,871

Other (expenses) income:
Interest expense, net

5,099

3,062

2,839

3,385

3,193

3,656

5,271

508

499

672

Interest income

-

-

-

-

-

0

103

1,090

737

713

Other expense

207

31

281

886

1,489

1,645

2,707

2,096

1,503

1,293

Other expense, net

-5,306

-3,093

-3,120

-4,271

-4,682

-5,301

-7,875

-1,514

-1,265

-1,252

Loss from continuing operations before income tax benefit

-14,702

-17,263

-14,295

-3,253

-8,131

5,186

-1,587

-5,422

10,698

19,619

Income tax benefit

-3,556

-11,036

-7,243

40,337

-4,743

2,839

-376

-239

2,581

7,307

Net loss from continuing operations

-11,146

-6,227

-7,052

-

-

-

-

-

-

-

Income from discontinued operations, net of income tax

72,486

22,562

12,060

-

-

-

-

-

-

-

Net income (loss)

61,340

16,335

5,008

-43,590

-3,388

2,347

-1,211

-5,183

8,117

12,312

Loss per share continuing operations - basic (usd per share)

-0.30

-0.17

-0.19

-

-

-

-

-

-

-

Loss per share continuing operations - diluted (usd per share)

-0.30

-0.17

-0.19

-

-

-

-

-

-

-

Income per share discontinued operations - basic (usd per share)

1.93

0.61

0.33

-

-

-

-

-

-

-

Income per share discontinued operations - diluted (usd per share)

1.93

0.61

0.33

-

-

-

-

-

-

-

Income (loss) per share
Basic (in usd per share)

1.64

0.44

0.14

-1.21

-0.09

0.07

-0.03

-0.20

0.33

0.50

Diluted (in usd per share)

1.64

0.44

0.14

-1.21

-0.09

0.07

-0.03

-0.20

0.32

0.50

Basic weighted average shares outstanding (in shares)

37,484

37,075

36,616

36,161

35,683

35,135

34,817

25,382

24,870

24,580

Diluted weighted average shares outstanding (in shares)

37,485

37,074

36,616

36,161

35,683

35,439

34,817

25,382

25,132

24,787